Appleby Bermuda Guides Organon’s Strategic Acquisition of Dermavant Sciences.
Appleby Bermuda assisted Organon & Co with the acquisition of Dermavant Sciences Ltd through a merger under Bermuda law. Organon (NYSE: OGN) is a global healthcare company focused on enhancing women’s health. Dermavant is committed to developing and commercializing innovative treatments in immuno-dermatology.
The Appleby Bermuda team was led by Partner Sally Penrose and included Senior Associate Katie Blundy, Associate Ojeda Smith and Trainee Mya Gibbons.
